Key result
Review summarizes approved therapies and the application of adult treatment algorithms to pediatric pulmonary hypertension.
Why the study?
The number of approved therapies for pulmonary hypertension is increasing, necessitating a review of their pediatric use and comparison to adult treatment algorithms.
This review summarizes the literature from 2006-2011 on pediatric pulmonary arterial hypertension therapies and adapts adult treatment algorithms for children.
Answers are grounded in this paper and cite their sources.
Supports adaptation of adult PAH algorithms in children where data are sparse; leaves open the need for updated pediatric trials.
The number of approved therapies for pulmonary hypertension continues to increase. This article reviews the literature related to pediatric use of these therapies from the past 5 years. The evidence-based algorithm for pulmonary hypertension treatment in adults is discussed with respect to children.
No takes yet. Share an insight, caveat, or question.
Delphine Yung (2011) studied this question. Approved therapies for pediatric pulmonary hypertension and the application of adult evidence-based treatment algorithms to children are reviewed based on literature from the past 5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: